Search for: "JANSSEN PHARMACEUTICALS"
Results 21 - 40
of 570
Sorted by Relevance
|
Sort by Date
1 Nov 2015, 9:57 pm
Par Pharmaceutical Inc. et al. 1:15-cv-00679; filed August 3, 2015 in the District Court of Delaware • Plaintiffs: Janssen Biotech Inc.; Janssen Oncology Inc.; Janssen Research & Development LLC • Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
4 Jan 2016, 7:49 am
In her defective drug lawsuit against Ortho-McNeil-Janssen Pharmaceuticals, a neurologist testified as an expert witness that ORTHO EVRA was a major contributing cause of her stroke. [read post]
14 Nov 2013, 5:00 am
It was recently announced that the state of Vermont will receive almost $1.4M in the consumer fraud lawsuit against Johnson & Johnson and Janssen Pharmaceuticals. [read post]
29 Dec 2013, 9:15 pm
Janssen Pharmaceuticals Inc. et al. v. [read post]
1 Apr 2024, 10:58 am
by Dennis Crouch In April 2024, the Federal Circuit issued a significant decision vacating a district court’s judgment that Janssen Pharmaceuticals’ dosing regimen patent claims were nonobvious. [read post]
14 Jun 2015, 8:59 pm
Janssen Pharmaceuticals Inc. v. [read post]
12 Oct 2021, 5:12 pm
Janssen, 425 F. [read post]
16 Apr 2012, 9:49 pm
Cir. 2008), and Janssen Pharmaceutica, N.V. v. [read post]
16 Mar 2021, 1:15 pm
In 2019, Janssen Pharmaceuticals sued Mylan Laboratories in district court for infringing U.S. [read post]
10 Nov 2014, 11:39 am
Janssen Issues Drug Recall for Xarelto After Discovering Contamination Johnson & Johnson’s pharmaceutical subsidiary Janssen issued a drug recall in mid-October for 13,500 bottles of their controversial blood thinner, Xarelto, after learning of a microbial infection in a sample. [read post]
18 May 2014, 8:42 pm
Mylan Pharmaceuticals Inc. et al. 1:14-cv-00594; filed May 12, 2014 in the District Court of Delaware • Plaintiffs: Alza Corp.; Janssen Pharmaceuticals Inc. [read post]
20 Jul 2016, 7:25 am
Largest Verdict Thus Far Against Jansen for $70 Million in Risperdal Trial According to Reuters, Janssen Pharmaceuticals, a unit of Johnson & Johnson, was hit with a $70 million verdict in a Risperdal trial last week, marking the largest verdict against Janssen thus far in this ongoing litigation. [read post]
1 Feb 2009, 3:13 pm
...in connection with alleged off-label promotions of Risperdal-manufacturer Janssen Pharmaceuticals, as reported by Drug & Device Law. [read post]
20 Jun 2011, 7:47 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., a member of the Johnson and Johnson family, has issued a recall of about 40,000 bottles of Risperdal and its generic form. [read post]
16 Mar 2021, 1:15 pm
In 2019, Janssen Pharmaceuticals sued Mylan Laboratories in district court for infringing U.S. [read post]
23 May 2012, 9:22 pm
Searle, LLC • Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
9 Jan 2014, 2:02 pm
From a relatively quick review of the medical literature we could find that the association between Janssen Pharmaceuticals antipsychotic drug Risperdal and the development of breasts in boys or men, i.e. [read post]
25 Nov 2013, 1:37 pm
Johnson & Johnson’s Janssen Pharmaceuticals unit has lost its second drug injury verdict in a month—this one for $11 million. [read post]
9 May 2014, 2:44 pm
Overton denied a motion by Johnson and Johnson subsidiary Janssen Pharmaceuticals for a new trial, upholding the original award for the family of Brayden Gurley. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
